FLS vs MRNA · P/E 25, $7.01B cap vs rev $145.0M
Flowserve Corporation (FLS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Flowserve Corporation (FLS) is a specialty industrial machinery company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported FLS revenue for 2026-06-30 was $0. Net income was $180.7M. FLS currently screens at market cap $7.01B and trailing P/E 25.1.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
FLS currently screens at market cap $7.01B and trailing P/E 25.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the FLS and MRNA stock pages for the full models.
Not investment advice.